 |
PDBsum entry 3f7d
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
3f7d
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structure of sf-1 bound by different phospholipids: evidence for regulatory ligands.
|
 |
|
Authors
|
 |
E.P.Sablin,
R.D.Blind,
I.N.Krylova,
J.G.Ingraham,
F.Cai,
J.D.Williams,
R.J.Fletterick,
H.A.Ingraham.
|
 |
|
Ref.
|
 |
Mol Endocrinol, 2009,
23,
25-34.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Despite the fact that many nuclear receptors are ligand dependent, the existence
of obligate regulatory ligands is debated for some receptors, including
steroidogenic factor 1 (SF-1). Although fortuitously bound bacterial
phospholipids were discovered in the structures of the SF-1 ligand-binding
domain (LBD), these lipids might serve merely as structural ligands. Thus, we
examined whether exogenously added phospholipids would exchange for these
bacterial lipids and bind to SF-1. Here, we report the first crystal structure
of the SF-1 LBD bound by the exchanged phosphatidylcholine. Although the bound
phosphatidylcholine phospholipid mimics the conformation of bound bacterial
phosphoplipids, two surface loops, L2-3 and L11-12, surrounding the entrance to
the pocket vary significantly between different SF-1 LBD structures. Based on
this observation, we hypothesized that a bound ligand might control the
conformations of loops L2-3 and L11-12, and that conserved residues in these
dynamic loops could influence ligand binding and the receptor function.
Consistent with this hypothesis, impaired phospholipid exchange and diminished
transcriptional activity were observed for loop L11-12 SF-1 mutants and for the
loop L2-3 human mutant R255L. The endocrine disease associated with this L2-3
mutation coupled with our cellular and biochemical data suggest that critical
residues at the mouth of the ligand-binding pocket have evolved for efficient
binding of phospholipid ligands and for achieving optimal SF-1 activity.
|
 |
|
|
|
|
 |